EyePoint Pharmaceuticals ... (EYPT)
NASDAQ: EYPT
· Real-Time Price · USD
11.09
0.24 (2.21%)
At close: Aug 15, 2025, 3:59 PM
11.09
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT
EyePoint Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -146.78M | -130.87M | -103.57M | -86.82M | -78.92M | -70.8M | -100.15M | -105.96M | -102.44M | -102.25M | -78.23M | -76.51M | -67.11M | -58.42M | -54.45M | -41.56M | -44.5M |
Depreciation & Amortization | 1.73M | 1.54M | 1.19M | 892K | 662K | 464K | 687K | 1.28M | 1.85M | 2.45M | 2.81M | 2.8M | 2.78M | 2.77M | 2.74M | 2.7M | 2.69M |
Stock-Based Compensation | 31.86M | 36.74M | 32.43M | 28.61M | 21.71M | 12.06M | 11.83M | 11.4M | 13.75M | 14.18M | 13.62M | 12.9M | 9.94M | 7.45M | 5.9M | 5.82M | 5.38M |
Other Working Capital | -9.89M | -51K | -9.99M | -40.98M | 36.27M | 44.48M | 56.11M | 69.68M | -2.28M | -2.48M | -5.97M | -5.93M | -5.97M | -5.99M | 15.06M | 15.58M | 15.74M |
Other Non-Cash Items | -33.02M | -12.52M | -11.32M | 13.51M | 14.47M | -4.54M | 18.29M | 21.8M | 21.74M | 23.65M | 1.51M | 1.88M | 2.15M | 628K | 673K | 1.03M | 1.38M |
Deferred Income Tax | n/a | n/a | 83K | 3.77M | 5.81M | 5.81M | 5.72M | 2.04M | n/a | n/a | 1.28M | 1.28M | -787K | -787K | -1.16M | -1.16M | 905K |
Change in Working Capital | -1.29M | -1.1M | -12.27M | -29.6M | 43.15M | 58.88M | 76.02M | 83.9M | 3.42M | -3.02M | -10.07M | -6.08M | -2.12M | -1.74M | 18.76M | 14.56M | 20.97M |
Operating Cash Flow | -148.18M | -126.23M | -113.49M | -89.66M | -12.46M | 1.88M | 12.4M | 14.46M | -61.68M | -65M | -69.08M | -63.74M | -55.16M | -50.1M | -27.53M | -18.61M | -13.19M |
Capital Expenditures | -3.13M | -4.05M | -4.55M | -4.7M | -4.19M | -3.48M | -3.19M | -2.66M | -2.48M | -2.15M | -1.56M | -498K | -305K | -156K | -348K | -345K | -346K |
Cash Acquisitions | n/a | n/a | 46.27M | 46.27M | 32.4M | 32.16M | -14.66M | -22.14M | -8.27M | -7.92M | -7.36M | 110K | 110K | n/a | n/a | n/a | n/a |
Purchase of Investments | -437.73M | -398.3M | -283.49M | -234.26M | -52.19M | -55.12M | -19.35M | -52.88M | -79.75M | -139.12M | -158.58M | -125.05M | -95.26M | -32.97M | n/a | n/a | n/a |
Sales Maturities Of Investments | 236.08M | 178.86M | 113.36M | 50.5M | 41.78M | 55.28M | 99.28M | 140.28M | 153.5M | 124M | 77M | 36M | 6M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -155.35M | -133.35M | -179.62M | -183.76M | -10.4M | -32.16M | 14.66M | 22.14M | 8.48M | 8.12M | -25.4M | -32.87M | -33.08M | -32.97M | n/a | n/a | n/a |
Investing Cash Flow | -200.64M | -219.35M | -170.54M | -188.46M | -14.6M | -3.31M | 76.75M | 84.74M | 71.26M | -17.27M | -83.15M | -89.55M | -89.56M | -33.12M | -348K | -345K | -346K |
Debt Repayment | -140K | -105K | -73K | n/a | -35.3M | -40.48M | -40.51M | -40.55M | -5.28M | -191K | -201K | -209K | -215K | -146K | -13.91M | -13.88M | -11.81M |
Common Stock Repurchased | -156K | -4.51M | -4.51M | -4.43M | -4.36M | -169K | -193K | -193K | -214K | -295K | -271K | -7.49M | -7.47M | -7.22M | -7.22M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 11.57M | 12.61M | 14.7M | 13.09M | 11.4M | 11.35M | 9.04M | -1.2M | -77K | -740K | -632K | 6.6M | 6.83M | 7.3M | 6.39M | -861K | -920K |
Financial Cash Flow | 162.96M | 164.02M | 230.82M | 229.29M | 192.3M | 187.07M | -31.47M | -41.74M | -5.36M | -690K | 107.88M | 107.79M | 107.69M | 216.9M | 118.87M | 123.77M | 125.81M |
Net Cash Flow | -185.71M | -181.41M | -53.05M | -48.83M | 165.25M | 185.63M | 57.67M | 57.46M | 4.22M | -82.96M | -44.35M | -45.5M | -37.03M | 133.68M | 90.98M | 104.82M | 112.28M |
Free Cash Flow | -151.31M | -130.28M | -118.04M | -94.36M | -16.65M | -1.61M | 9.21M | 11.8M | -64.17M | -67.16M | -70.65M | -64.23M | -55.46M | -50.25M | -27.88M | -18.96M | -13.54M |